Comments
Loading...
Verona Pharma (VRNA) Forecast
NewsEarningsVerona Pharma (VRNA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVerona Pharma (NASDAQ:VRNA) Stock Quotes, Forecast and News Summary
Verona Pharma Stock (NASDAQ: VRNA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Verona Pharma (VRNA) stock?
You can purchase shares of Verona Pharma (NASDAQ:VRNA) through any online brokerage.
Who are Verona Pharma (VRNA) competitors?
Other companies in Verona Pharma’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Haleon (NYSE:HLN).
What is the forecast, or price target, for Verona Pharma (VRNA) stock?
Verona Pharma has a consensus price target of $53.88.
What is the current price for Verona Pharma (VRNA)?
The stock price for Verona Pharma (NASDAQ: VRNA) is $65.93 last updated February 21, 2025 at 10:39 AM EST.
Does Verona Pharma (VRNA) pay a dividend?
There are no upcoming dividends for Verona Pharma.
When is Verona Pharma (NASDAQ:VRNA) reporting earnings?
Verona Pharma’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Verona Pharma (VRNA) going to split?
There is no upcoming split for Verona Pharma.
What sector and industry does Verona Pharma (VRNA) operate in?
Verona Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.